Viewpoint: Bullish
When we stand back and look at global stocks over the last 20-years the acceleration since the pandemic has been amazing until of course we consider how much “free cash” has been pumped into the economic system by central banks. Pullbacks are inevitable but the current momentum is hard to argue against even if central banks are hoping to rein in their…
US stocks continue to grind higher with no sell signals in-sight and although most of the heavy lifting is being done by the mega-cap tech stocks the broad based Russell 3000 Index still continues to post fresh all-time highs with almost boring monotony. Similar to the local market we are keen buyers of pullbacks by US stocks but 2nd guessing…
When we consider that heavyweights Commonwealth Bank (CBA), CSL Ltd (CSL) and especially BHP Group (BHP) are already trading well below their respective 2021 highs its hard to imagine a significantly deeper correction this side of Christmas. However its important to remember MM is a buyer of dips but the next pullback may not unfold until…
The ASX200 is a few days into what’s been a very quiet start to September, over the last decade August & September have combined to fall an average of -3.8% but last month’s +1.9% advance should have already warned statisticians that there’s nothing normal about the strength of the post COVID stock market rally – at MM we’re sticking with…
PDN +22%: Uranium stocks roared today, Paladin (PDN) up ~20% as the Uranium price starts to move higher. Spot uranium is at US$37/lb, its highest level since early 2016.
NHF disappointed investors last month after missing profit expectations by ~5% although the downside 20% rerating of the stock was largely because of the very conservative rhetoric towards next year citing last year as abnormally good given the pandemic tailwinds – interestingly if this is to be believed then MPL is trading too rich, or perhaps…
Last month MPL delivered an impressive 40% lift in profits for FY21 as the coronavirus delivered an expected strong tailwind to the business. People have significantly prioritized their health since the pandemic swept the world and who can blame them. The outlook for MPL is solid with the company fairly optimistic moving forward although…
MM followed our improved outlook towards insurance via buying IAG in mid-August, we remain happy with this purchase believing the stocks great value under $5.50.
The Australian private health insurance sector has been a beneficiary of COVID courtesy of a number of factors but an obvious one being lower claims as many of us endure ongoing lockdowns. The pandemic has led a lot of Australians to consider private health cover for the first time with Medibank Private enjoying their highest growth in membership for…
Xero (XRO) has regularly been our “go to” tech stock to illustrate how we see the market unfolding through 2021 and so far its rewarded both our investment and thesis towards it as a market indicator. XRO continues to look very bullish and we anticipate new all-time highs into Christmas but investors should be mindful that this quality growth stock…
